ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,808Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 809

$500K Total Retail Price of All Prescriptions

Rank: 126 out of 809

503 Patients Receiving at Least One Drug in Part D
91% Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Minnesota
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 503 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 503 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 755 701 174 1 1
LISINOPRIL 647 615 137 2 2
WARFARIN SODIUM 536 531* 75 3 9
FUROSEMIDE 504 483 83 4 6
METOPROLOL TARTRATE 436 419 77 5 10
OMEPRAZOLE 411 406* 85 6 4
AMLODIPINE BESYLATE 326 307 71 7 5
CITALOPRAM HBR 290 285* 56 8 18
LEVOTHYROXINE SODIUM 280 265 54 9 3
METFORMIN HCL 261 256* 54 10 14
POTASSIUM CHLORIDE 257 234 51 11 17
HYDROCHLOROTHIAZIDE 242 237* 64 12 11
ATORVASTATIN CALCIUM 219 214* 65 13 7
LOSARTAN POTASSIUM 195 190* 52 14 12
ATENOLOL 195 190* 48 14 8
GABAPENTIN 192 156 30 16 15
CLOPIDOGREL 190 185* 30 17 28
PRAVASTATIN SODIUM 189 178 45 18 20
NAMENDA 163 158* 14 19 47
ALLOPURINOL 139 127 24 20 26
MIRTAZAPINE 135 121 24 21 41
JANUVIA 131 126* 20 22 73
METOPROLOL SUCCINATE 131 126* 27 22 13
TERAZOSIN HCL 129 129 18 24 82
TAMSULOSIN HCL 126 104 23 25 25
FLUTICASONE PROPIONATE 117 112* 39 26 27
SERTRALINE HCL 113 108* 16 27 21
DONEPEZIL HCL 106 106 15 28 35
TRAZODONE HCL 104 75 23 29 22
PRAMIPEXOLE DIHYDROCHLORIDE 96 96 13 30 107
HYDROCODONE-ACETAMINOPHEN 89 77 20 S3 31 16
ISOSORBIDE MONONITRATE ER 87 82* 15 32 38
ALENDRONATE SODIUM 83 78* 17 33 23
TRAMADOL HCL 80 75* 22 34 19
RANITIDINE HCL 74 69* 17 35 37
METFORMIN HCL ER 73 68* 18 36 59
CRESTOR 72 67* 15 37 34
CARVEDILOL 70 65* 14 38 33
PREDNISONE 69 64* 34 39 24
TRIAMCINOLONE ACETONIDE 68 63* 29 40 89
PANTOPRAZOLE SODIUM 56 45 13 41 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 50* 15 42 30
POLYETHYLENE GLYCOL 3350 54 49* 20 43 43
DOXAZOSIN MESYLATE 52 52 13 44 67
LIDODERM 52 47* 12 44 112
LORAZEPAM 51 46* 13 B 46 32
SYNTHROID 51 51 11 46 130
CYMBALTA 51 <11 <11 46 62
PROAIR HFA 50 45* 16 49 42
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.